|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cohen M, Pierredon S, Wuillemin C, Delie F
and Petignat P: Acellular fraction of ovarian cancer ascites induce
apoptosis by activating JNK and inducing BRCA1, Fas and FasL
expression in ovarian cancer cells. Oncoscience. 1:262–271. 2014.
View Article : Google Scholar
|
|
4
|
Sun ZL, Tang YJ, Wu WG, Xing J, He YF, Xin
DM, Yu YL, Yang Y and Han P: AZD1480 can inhibit the biological
behavior of ovarian cancer SKOV3 cells in vitro. Asian Pac J Cancer
Prev. 14:4823–4827. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holschneider CH and Berek JS: Ovarian
cancer: Epidemiology, biology and prognostic factors. Semin Surg
Oncol. 19:3–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vaughan S, Coward JI, Bast RC Jr, Berchuck
A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R,
Etemadmoghadam D, et al: Rethinking ovarian cancer: Recommendations
for improving outcomes. Nat Reviews Cancer. 11:719–725. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Z, Jiang W, Zhang Z, Qian M and Du B:
Nitidine chloride inhibits LPS-induced inflammatory cytokines
production via MAPK and NFkappab pathway in raw 264.7 cells. J
Ethnopharmacol. 144:145–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Del Poeta M, Chen SF, Von Hoff D, Dykstra
CC, Wani MC, Manikumar G, Heitman J, Wall ME and Perfect JR:
Comparison of in vitro activities of camptothecin and nitidine
derivatives against fungal and cancer cells. Antimicrob Agents
Chemother. 43:2862–2868. 1999.PubMed/NCBI
|
|
9
|
Fang Z, Tang Y, Jiao W, Xing Z, Guo Z,
Wang W, Xu Z and Liu Z: Nitidine chloride induces apoptosis and
inhibits tumor cell proliferation via suppressing ERK signaling
pathway in renal cancer. Food Chem Toxicol. 66:210–216. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, Wang J, Lin L, He L, Wu Y, Zhang
L, Yi Z, Chen Y, Pang X and Liu M: Inhibition of STAT3 signaling
pathway by nitidine chloride suppressed the angiogenesis and growth
of human gastric cancer. Mol Cancer Ther. 11:277–287. 2012.
View Article : Google Scholar
|
|
11
|
Liao J, Xu T, Zheng JX, Lin JM, Cai QY, Yu
DB and Peng J: Nitidine chloride inhibits hepatocellular carcinoma
cell growth in vivo through the suppression of the JAK1/STAT3
signaling pathway. Int J Mol Med. 32:79–84. 2013.PubMed/NCBI
|
|
12
|
Sun M, Zhang N, Wang X, Cai C, Cun J, Li
Y, Lv S and Yang Q: Nitidine chloride induces apoptosis, cell cycle
arrest and synergistic cytotoxicity with DOX in breast cancer
cells. Tumour Biol. 35:10201–10212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fang Z, Tang Y, Jiao W, Xing Z, Guo Z,
Wang W, Shi B, Xu Z and Liu Z: Nitidine chloride inhibits renal
cancer cell metastasis via suppressing AKT signaling pathway. Food
Chem Toxicol. 60:246–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pan X, Han H, Wang L, Yang L, Li R, Li Z,
Liu J, Zhao Q, Qian M, Liu M and Du B: Nitidine chloride inhibits
breast cancer cells migration and invasion by suppressing c-Src/FAK
associated signaling pathway. Cancer Lett. 313:181–191. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai Q, Lin J, Wei L, Zhang L, Wang L, Zhan
Y, Zeng J, Xu W, Shen A, Hong Z and Peng J: Hedyotis diffusa willd
inhibits colorectal cancer growth in vivo via inhibition of STAT3
signaling pathway. Int J Mol Sci. 13:6117–6128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Surh YJ: Cancer chemoprevention with
dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thomasset SC, Berry DP, Garcea G, Marczylo
T, Steward WP and Gescher AJ: Dietary polyphenolic
phytochemicals-promising cancer chemopreventive agents in humans? A
review of their clinical properties. Int J Cancer. 120:451–458.
2007. View Article : Google Scholar
|
|
19
|
Zhang Y, Zhuang Z, Meng Q, Jiao Y, Xu J
and Fan S: Polydatin inhibits growth of lung cancer cells by
inducing apoptosis and causing cell cycle arrest. Oncology lett.
7:295–301. 2014.
|
|
20
|
Reed JC: Bcl-2: Prevention of apoptosis as
a mechanism of drug resistance. Hematol Oncol Clin North Am.
9:451–473. 1995.PubMed/NCBI
|
|
21
|
Antonsson B: Bax and other pro-apoptotic
Bcl-2 family 'killer-proteins' and their victim the mitochondrion.
Cell Tissue Res. 306:347–361. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Crompton M: Bax, Bid and the
permeabilization of the mitochondrial outer membrane in apoptosis.
Curr Opin Cell Biol. 12:414–419. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baffy G, Miyashita T, Williamson JR and
Reed JC: Apoptosis induced by withdrawal of interleukin-3 (IL-3)
from an IL-3-dependent hematopoietic cell line is associated with
repartitioning of intracellular calcium and is blocked by enforced
Bcl-2 oncoprotein production. J Biol Chem. 268:6511–6519.
1993.PubMed/NCBI
|
|
24
|
Precht TA, Phelps RA, Linseman DA, Butts
BD, Le SS, Laessig TA, Bouchard RJ and Heidenreich KA: The
permeability transition pore triggers Bax translocation to
mitochondria during neuronal apoptosis. Cell Death Differ.
12:255–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu Q: Restoring p53-mediated apoptosis in
cancer cells: New opportunities for cancer therapy. Drug Resist
Updat. 9:19–25. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Somanath PR, Vijai J, Kichina JV, Byzova T
and Kandel ES: The role of PAK-1 in activation of MAP kinase
cascade and oncogenic transformation by Akt. Oncogene.
28:2365–2369. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: A play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gardai SJ, Hildeman DA, Frankel SK,
Whitlock BB, Frasch SC, Borregaard N, Marrack P, Bratton DL and
Henson PM: Phosphorylation of Bax Ser184 by Akt regulates its
activity and apoptosis in neutrophils. J Biol Chem.
279:21085–21095. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Khan KH, Blanco-Codesido M and Molife LR:
Cancer therapeutics: Targeting the apoptotic pathway. Crit Rev
Oncol Hematol. 90:200–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Octavia Y, Tocchetti CG, Gabrielson KL,
Janssens S, Crijns HJ and Moens AL: DOX-induced cardiomyopathy:
From molecular mechanisms to therapeutic strategies. J Mol Cell
Cardiol. 52:1213–1225. 2012. View Article : Google Scholar : PubMed/NCBI
|
